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CLINICAL RESEARCH

Potentially Avoidable Readmissions
in United States Hemodialysis Patients
Anna T. Mathew1, Lisa Rosen2, Renee Pekmezaris3, Andrzej Kozikowski3, Daniel W. Ross3,
Thomas McGinn3, Kamyar Kalantar-Zadeh4,5,6 and Steven Fishbane3
1
McMaster University, Hamilton Health Sciences Center, Hamilton, Ontario, Canada; 2Feinstein Institute for Medical Research,
Northwell Health, Manhasset, New York, USA; 3Hofstra Northwell School of Medicine, Northwell Health, Great Neck, New
York, USA; 4Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine, School of Medicine, Orange, California, USA; 5Fielding School of Public Health at UCLA,
Los Angeles, California, USA; and 6Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, California, USA

Introduction: Patients with end-stage kidney disease have a high risk of 30-day readmission to hospital.
These readmissions are ﬁnancially costly to health care systems and are associated with poor healthrelated quality of life. The objective of this study was to describe and analyze the frequency, causes,
and predictors of 30-day potentially avoidable readmission to hospital in patients on hemodialysis.
Methods: We conducted a retrospective cohort study using the US Renal Data System data from January
1, 2008, to December 31, 2008. A total of 107,940 prevalent United States hemodialysis patients with
248,680 index hospital discharges were assessed for the main outcome of 30-day potentially avoidable
readmission, as identiﬁed by a computerized algorithm.
Results: Of 83,209 30-day readmissions, 59,045 (70.1%) resulted in a 30-day potentially avoidable readmission. The geographic distribution of 30-day potentially avoidable readmission in the United States
varied by state. Characteristics associated with 30-day potentially avoidable readmission included the
following: younger age, shorter time on hemodialysis, at least 3 or more hospitalizations in preceding 12
months, black race, unemployed status, treatment at a for-proﬁt facility, longer length of index hospital
stay, and index hospitalizations that involved a surgical procedure. The 5-, 15-, and 30-day potentially
avoidable readmission cumulative incidences were 6.0%, 15.1%, and 25.8%, respectively.
Conclusion: Patients with end-stage kidney disease on maintenance hemodialysis are at high risk for
30-day readmission to hospital, with nearly three-quarters (70.1%) of all 30-day readmissions being
potentially avoidable. Research is warranted to develop cost-effective and transferrable interventions that
improve care transitions from hospital to outpatient hemodialysis facility and reduce readmission risk for
this vulnerable population.
Kidney Int Rep (2018) 3, 343–355; https://doi.org/10.1016/j.ekir.2017.10.014
KEYWORDS: avoidable; epidemiology; ESKD; hemodialysis; hospitalization; readmission
ª 2017 International Society of Nephrology. Published by Elsevier Inc. This is an open access article under the CC BYNC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

ospital readmission is associated with poor quality
of life and health outcomes,1,2 as well as high
costs. In the United States, an estimated $17 billion
spent on return trips to the hospital can be saved
annually with appropriate management.3 Given the
high societal, emotional, and ﬁnancial costs, research
has focused on identifying patient populations at high
risk for readmission, as well as developing and testing
interventions to reduce this risk. For example, more
than 40 randomized controlled trials have tested
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interventions to reduce readmission risk in patients
with congestive heart failure.4
Patients with end-stage kidney disease (ESKD) on
maintenance hemodialysis (HD) face particularly high
rates of readmission to hospital. In 2013, 34.9% of HD
patients were readmitted within 30 days of an index
hospitalization.5 In comparison, 19% of the general
Medicare population6 and approximately 25% of patients with congestive heart failure7 are readmitted to
hospital within 30 days of an index hospital discharge.
Hospitalizations in ESKD are exceptionally costly, and
38% of the nearly $30 billion in annual Medicare expenditures for ESKD is spent on acute inpatient care.5
After an index hospital discharge, a patient with
ESKD will experience 1 of 3 outcomes: remain out of
hospital, be readmitted to hospital, or die. Perhaps
343
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related to deﬁnitions levied by pay-for-performance
programs,8 readmissions are often deﬁned as within
30 days of an index hospitalization, and are categorized
as planned or unplanned. Planned readmissions are
scheduled during or shortly after the index hospitalization, and are often for a procedure, chemotherapy,
transplant, or rehabilitation. Approximately 10% of all
readmissions are planned in the United States.6,9 An
example scenario would be a patient admitted for a
urologic procedure, with a planned readmission within
10 days for stent removal.
Of the remaining unplanned readmissions, some are
unavoidable, whereas others might be avoidable with
appropriate transitional and/or ambulatory care after
index hospital discharge. For example, if a patient is
discharged from hospital after an episode of atrial
ﬁbrillation, then readmitted within 30 days with acute
cholecystitis, this readmission would be considered
unplanned and also unavoidable. Conversely, if the
same patient discharged from hospital after an episode
of atrial ﬁbrillation is then readmitted within 30 days
with an episode of congestive heart failure, this would
be considered an unplanned, but potentially avoidable
readmission to hospital. The literature shows much
variation regarding the proportion of potentially
avoidable readmissions to hospital. In a recent systematic review, 27.1% of readmissions were deemed
potentially avoidable in general medicine patients,
ranging from 5% to 79%.10 Similarly, conditions in HD
patients who are ambulatory-sensitive (e.g., volume
overload, electrolyte imbalance) can result in readmission but may have been avoided with the appropriate transitional care on discharge.
Vest et al.11 recently published a systematic review
of readmissions, and deﬁned a potentially avoidable
readmission as: “an unintended and undesired subsequent post-discharge hospitalization, where the probability is subject to the inﬂuence of multiple factors.”
However, the methodology to identify an avoidable
readmission varies widely in the literature, often based
on subjective criteria,12–15 or predeﬁned lists of
discharge categories or diagnoses.16,17 These methodologies lack generalizability and are inadequate for use
with large datasets or more sophisticated analyses. 3M
Health Information Systems has developed a proprietary potentially preventable readmissions classiﬁcation system,18 but its use for research purposes is
limited. Halfon et al.19 derived an algorithm using
administrative data (International Classiﬁcation of Diseases, Ninth Revision codes and diagnosis-related
group [DRG] codes) in a general medical inpatient
population in Switzerland. The algorithm had 96%
sensitivity and 95.7% speciﬁcity against the gold
standard of chart review and has been used for research
344
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purposes to aid in the identiﬁcation of predictive factors for potentially avoidable readmission in the United
States.20
Despite the high risks, negative impact on patient
outcomes, and ﬁnancial consequences, there is a
paucity of literature on the frequency and predictors of
potentially avoidable readmission in ESKD,21 and lack
of a standardized metric to deﬁne potentially avoidable
readmission. Although some studies and reports have
described all-cause,22–25 or cause-speciﬁc5,26–29 readmissions in ESKD, potentially avoidable readmissions
have not been previously studied. Given these gaps in
the literature, we conducted an observational study
using the US Renal Data System (USRDS) database to
describe and analyze the frequency, causes, and predictors associated with potentially avoidable
readmission.
METHODS
This study was conducted and reported in accordance
with Strengthening the Reporting of Observational
Studies in Epidemiology guidelines.30
Data Source, Setting, and Participants
We conducted an observational cohort study of the
USRDS database using data from the core and hospitalized datasets. Patients with Medicare as their
primary insurance type, 18 to 95 years of age at
day $91 after ﬁrst ESKD service, with acute hospital
discharges from January 1, 2008, to November 30,
2008, were included in the study population. All
30-day readmissions were assessed until December 31,
2008. Data were obtained on patient characteristics and
comorbidities at baseline from the 2728 medical
evidence form. Data on comorbid conditions were also
collected from claims over a 3- to 6-month entry period
(dependent on date of ﬁrst ESKD service). Hospitalization claims with discharge status of “left against
medical advice,” or DRG of 998, 999, or 000 (invalid or
ungroupable) were excluded. Hospital discharges with
primary reason for admission being rehabilitation (DRG
945, 946), psychiatric diagnosis (DRG 876 – 887), cancer
(International Classiﬁcation of Diseases, Ninth Revision
principal discharge code of 140.xx-172.xx, 174.xx208.xx, 230.xx-231.xx, 233.xx-234.xx), or renal
transplant (DRG 652) were similarly excluded. An index hospital discharge was eligible only if it occurred
during an HD treatment period, thus excluding
patients on peritoneal dialysis. Patients listed as
“recovered function,” with an unknown ESKD start
date, who died during the index hospitalization, or
with conﬂicting information on 1995 and 2005 medical
evidence forms were also excluded. The study protocol
was approved for Exempt Status by the Institutional
Kidney International Reports (2018) 3, 343–355
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Review Board of Northwell Health and issued a waiver
of authorization as per 45 CFR 164.512 for the use and
disclosure of information for research purposes.
Outcome Deﬁnitions
Thirty-Day Potentially Avoidable Readmission

The main study outcome was the proportion of index
hospitalizations resulting in a potentially avoidable
30-day readmission (30-day PAR). Thirty-day PAR was
identiﬁed by a computerized algorithm that uses
routinely available International Classiﬁcation of Diseases, Ninth Revision and DRG codes from administrative data. The algorithm was initially developed
using a random sample of 3474 hospitalized patients
from across Switzerland. Prediction was based on a
Poisson regression model, with intra-sample sensitivity
and speciﬁcity of the computerized screening algorithm
reaching 96%, compared with a gold standard of systematic medical record review to identify potentially
avoidable readmissions.19 A subsequent validation
study of the predictive value of the computerized
algorithm was then conducted, including 131,809
hospitalizations, and a random sample of 570 discharge/
readmission pairs for chart review by 2 trained independent physicians.31 In this study, the predictive
value was very good at 78%, for the computerized
algorithm identifying potentially avoidable readmission. For a readmission to be categorized as potentially avoidable, the algorithm requires the readmission
(i) is related to at least 1 diagnosis already known
during the previous hospital stay; (ii) was unforeseen at
the time of the previous hospital discharge; and (iii)
occurs within the 30 days after the previous hospital
discharge.
Thirty-Day Planned Readmission

As per the Planned Readmissions Algorithm version 2.1
published by the Centers for Medicare and Medicaid
Services,32 3 principles guide the identiﬁcation of a
planned readmission: (i) a few speciﬁc, limited types
of care are always considered planned (obstetrical
delivery, transplant surgery, maintenance chemotherapy/radiotherapy/immunotherapy, rehabilitation);
(ii) a planned readmission is deﬁned as a nonacute
readmission for a scheduled procedure; and (iii) admissions for acute illness or for complications of care
are never planned. For this study, we deﬁned a planned
readmission using criteria for “planned readmission”
from the National Quality Forum technical report on
all-cause readmissions,9 or for solely vascular access
reasons, as deﬁned by USRDS analytic methods.33
Thirty-Day
Unplanned
Readmissions

and

Unavoidable

These were deﬁned as all other hospitalizations occurring within 30 days of an index hospitalization that did
Kidney International Reports (2018) 3, 343–355

not meet the deﬁnition of potentially avoidable or
planned readmission.
Statistical Analysis
Patient demographic and comorbid characteristics were
obtained from patient proﬁle, hospitalization inpatient
data, facility standard analysis ﬁle, and the 2728 Centers for Medicare and Medicaid Services Medical Evidence form and expressed as categorical variables.
Descriptive statistics were used to describe the sample
of index hospitalizations. Demographic characteristics
included were gender, race, ethnicity, employment
status, HD facility, HD vintage in years, and cause of
ESKD. A comorbidity index, encompassing 11 comorbidities and validated for use in the ESKD population to
model outcomes of mortality and hospitalization, was
used to report the comorbidity burden and adjust for
potential confounding of the primary outcome of
30-day PAR.34 Comorbid characteristics included in the
index are atherosclerotic heart disease, congestive heart
failure, cerebrovascular disease, peripheral vascular
disease, other cardiac disease, chronic obstructive
pulmonary disease, gastrointestinal bleed, liver disease,
dysrhythmia, cancer, and diabetes. This index was
used to increase stability of effect estimates and
simplify comparisons. The comorbidity index
outperforms the Charlson Comorbidity Index in both
predictive ability and inference. Geographic-level
median income was described by linking USRDS data
to 2010 US census data by zip code, and unadjusted
risk of 30-day potentially avoidable readmission for
each state was mapped using Pitney Bowes MapInfo
(Troy, NY). There were no missing zip codes in our
ﬁnal sample and only 8700 patients (8%) did not have
income-level data and were excluded from the analysis.
Because missing data were uncommon, multiple
imputation was not performed.
Reason for index hospital discharge was reported
using Clinical Classiﬁcation Software (CCS) category.
The CCS is a diagnosis and procedure categorization
scheme based on International Classiﬁcation of Diseases, Ninth Revision codes developed with sponsorship from the Agency for HealthCare Research and
Quality for research purposes. The 5 most common
single-level CCS categories of index hospital discharge
that resulted in the largest proportions of 30-day PAR
were identiﬁed. We then tabulated the rate, proportion, and 5 most frequent causes of 30-day PAR that
resulted from each of these index hospitalization categories (deﬁned by single-level CCS category35).
Logistic regression using generalized estimating
equation methods was used to model 30-day PAR as a
function of each potential risk factor of interest, with
hospitalization as the unit of analysis. Generalized
345
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estimating equation estimation with robust SEs was
used to account for the clustering of multiple index
hospitalizations within a patient. Predictors that were
individually signiﬁcantly associated with 30-day PAR
(P < 0.05) were included in the ﬁnal multivariable
model. Predictors of interest included all demographic
and clinical characteristics, as well as dialysis facility
type and median income. All predictors, excluding
geographic-level median income and index admission
primary diagnosis, were signiﬁcant and included in the
ﬁnal model. To identify risk factors unique to PAR, we
repeated these multivariable models using all readmission, all readmission þ death, and PARþ death as
outcome of interest.
Time to potentially avoidable readmission was
analyzed using competing risks methodology,36
because deaths, and unplanned and planned readmissions represent competing risks to the primary
outcome of 30-day PAR (because the occurrence of any
of these events prevents PAR from being observed).
The cumulative incidence function for 30-day PAR was

AT Mathew et al.: HD Readmissions

used to estimate the probability of a potentially
avoidable readmission at 5, 10, 15, 20, 25, and 30 days
after an index hospital discharge. Index hospitalizations that experienced neither death nor any type of
readmission by 30 days postdischarge was considered
to be censored at 30 days. In sensitivity analyses, the
Kaplan-Meier method was also used, treating all events
other than a potentially avoidable readmission as
censored. All analyses assumed a 2-sided signiﬁcance
level of 0.05. All analyses were conducted using SAS
version 9.4 (SAS Institute Inc., Cary, NC).
RESULTS
Participant and Index Hospitalization
Characteristics
A total of 107,940 patients with 247,680 index hospitalizations met our predeﬁned inclusion criteria, and
were included in the study cohort (Figure 1). Of
346,671 possible adults, Medicare index admissions
with discharges that occurred between January 1,

Adult Medicare index discharges from
1/1/2008-11/30/2008 (n = 346,671)

Did not meet predefined exclusion criteria
(n = 64,337)

PotenƟally eligible index discharges
(n = 282,334)

Index admission did not occur during a
dialysis treatment period
(n = 10, 648)

PotenƟally eligible index discharges in
dialysis treatment period
(n = 271,686)

Hemodialysis treatment not given during
index admission
(n = 21,080)

PotenƟally eligible receiving
hemodialysis during index admission
(n = 250,606)

ConflicƟng data on 2728 Medical Evidence
forms
(n = 2926)

Included index discharges in study
cohort
(n = 247,680)
Figure 1. Study ﬂow diagram.
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2008, and November 30, 2008, 64,337 admissions were
excluded due to either death during the index admission, discharged after November 30, 2008, transferred
in another hospital or rehabilitation center, or some
other predeﬁned exclusion criteria (see Data Source,
Setting, and Participant section). Of those remaining,
10,648 admissions were removed because the index
admission did not occur during a treatment period. Of
those remaining, 21,080 were removed because the
treatment given during the index admission was not
HD. Finally of those remaining, 2,926 were removed
because of conﬂicting data on the medical evidence
forms. Patient and index hospitalization characteristics

stratiﬁed by the outcome of potentially avoidable
readmission are shown in Tables 1 and 2. At baseline
(i.e., time of index hospitalization discharge), the median patient age was 66 years with an interquartile
range of 53 to 76, 50% of patients were female, 38.9%
were of black race, 13.5% were of Hispanic ethnicity,
49% had diabetes as the primary cause for ESKD, and
74.6% dialyzed at for-proﬁt HD facilities. The median
time on HD (vintage) was 2.61 years (interquartile
range 1.20 to 4.87). When admitted to hospital, most
patients (43%) had between 1 and 3 prior hospitalizations in the preceding 12 months, with 30% having
had more than 3 prior hospitalizations in the preceding

Table 1. Baseline patient characteristics at index hospitalization in 107,940 patients and 247,680 hospitalizations
Total n [ 247,680

Potentially avoidable readmissiona
(n [ 59,045)

No potentially avoidable readmissiona
(n [ 188,635)

Standardized difference

66 (53–76)

65 (42–88)

66 (44–88)

0.08

Male

123,709 (49.9)

29,039 (49.2)

94,670 (50.2)

Female

123,971 (50.1)

30,006 (50.8)

93,965 (49.8)

White

138,904 (56.1)

31,925 (54.1)

106,979 (56.7)

Black

96,361 (38.9)

24,415 (41.4)

71,946 (38.1)

Asian

6955 (2.8)

1544 (2.6)

5411 (2.9)

Native American

4015 (1.6)

811 (1.4)

3204 (1.7)

Other

1372 (0.6)

330 (0.6)

1042 (0.6)

73 (0.0)

20 (0.0)

53 (0.0)

Hispanic

33,336 (13.5)

7,616 (12.9)

25,720 (13.6)

Non-Hispanic

208,835 (84.3)

50,178 (85.0)

158,657 (84.1)

5509 (2.2)

1251 (2.1)

4258 (2.3)

11,593 (4.7)

2,566 (4.4)

9,027 (4.8)

Characteristics, n (col %) or
median (interquartile range)
Age, yr

0.02

Gender

Race

Unknown

0.07

Ethnicity

Unknown

0.02

Employment status
Employed/Student

0.07

Homemaker

10,714 (4.3)

2,484 (4.2)

8,230 (4.4)

Retired – Disability/Medical LOA

64,332 (26.0)

15,443 (26.2)

48,889 (25.9)

Retired – Age

87,021 (35.1)

19,609 (33.2)

67,412 (35.7)

Unemployed

64,014 (25.9)

16,570 (28.1)

47,444 (25.2)

Missing/other

10,006 (4.0)

2,373 (4.0)

7633 (4.1)

44,037 (35,089–57,047)

43,661 (34,729–56,818)

44,146 (35,239–57,154)

0.03

2.61 (1.20–4.87)

2.56 (1.16–4.78)

2.63 (1.21–4.89)

0.03

<1 year

51,340 (20.7)

12,734 (21.6)

38,606 (20.5)

0.03

1–3 years

85,669 (34.6)

20,328 (34.4)

65,341 (34.6)

>3 years

110,671 (44.7)

25,983 (44.0)

84,688 (44.9)

21,662 (8.8)

4,859 (8.2)

16,803 (8.9)

Diabetes

121,811 (49.2)

28,886 (48.9)

92,925 (49.3)

Hypertension

70,995 (28.7)

17,147 (29.0)

53,848 (28.6)

Other

33,212 (13.4)

8,153 (13.8)

25,059 (13.3)

Nonproﬁt

49,851 (20.1)

11,475 (19.4)

38,376 (20.3)

Proﬁt

184,840 (74.6)

44,547 (75.5)

140,293 (74.4)

12,989 (5.2)

3023 (5.1)

9966 (5.3)

11.00 (8.00–13.00)

11.00 (9.00–13.00)

10.00 (7.00–13.00)

0.31

2.00 (0.00–4.00)

2.00 (1.00–5.00)

2.00 (0.00–4.00)

0.27

None

67,400 (27.2)

13,273 (22.5)

54,127 (28.7)

0.26

1–3

106,559 (43.0)

22,759 (38.6)

83,800 (44.4)

>3

73,721 (29.8)

23,013 (39.0)

50,708 (26.9)

Geographic-level income, $
Dialysis vintage years

ESKD primary cause
Glomerulonephritis/cystic kidney

0.03

Dialysis facility

Unknown
Comorbidity Index
Number of prior admissions

0.02

ESKD, end-stage kidney disease; LOA, leave of absence; Q, quartile.
a
Percentages represent row percentage.
Kidney International Reports (2018) 3, 343–355
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Table 2. Baseline characteristics of index hospitalizations
Characteristics n (col %) or
median (interquartile range)
LOS Index, d

Total
n [ 247,680

Potentially avoidable readmissiona
(n [ 59,045)

No potentially avoidable readmissiona
(n [ 188,635)

Standardized
difference

4.00 (2.00–7.00)

4.00 (2.00–8.00)

4.00 (2.00–7.00)

0.13

0–4

134,360 (54.3)

29,649 (50.2)

104,711 (55.5)

0.12

>4–8

64,517 (26.1)

15,837 (26.8)

48,680 (25.8)

>8

48,803 (19.7)

13,559 (23.0)

35,244 (18.7)

Primary surgical

61,477 (24.8)

14,261 (24.2)

47,216 (25.0)

Primary medical

186,203 (75.2)

44,784 (75.8)

141,419 (75.0)

17,469 (9.4)

3,680 (8.2)

13,789 (9.8)

168,734 (90.6)

41,104 (91.8)

127,630 (90.3)

Type of index hospitalization

0.05

Without surgical procedure
With surgical procedure
LOS, length of stay; Q, quartile.
a
Percentages represent row percentage

12 months. Seventy-ﬁve percent of index hospitalizations were for a primary medical reason, as identiﬁed
by DRG. The median length of stay for index hospitalizations was 4 days (interquartile range 2 to 7);
however, 20% of hospitalizations (n ¼ 48,803) had a
length of stay of more than 8 days.
Characteristics of 30-Day Readmissions
Of 247,680 index hospital discharges, 8584 patients
(3.5%) died within 30 days of index hospital discharge
(Figure 2). There were 83,209 index hospital discharges

that resulted in a 30-day readmission (33.6%). Of these,
59,045 were classiﬁed as potentially avoidable
readmissions (70.1%), 18,461 were unplanned and
unavoidable readmissions (22.2%), and 5703 readmissions (6.9%) were planned.
Table 3 shows the 5 most frequent causes for index
hospitalization that resulted in a 30-day PAR, with
corresponding 30-day PAR rates, and 5 most frequent
causes of 30-day PAR (by single-level CCS category).
Complication of a device, implant, or graft was the
most frequent index hospital discharge that resulted

Index hospital discharges
n = 247,680

30-day readmission
n = 83,209

30-day planned
readmission
n = 5703

30-day unplanned
and unavoidable
readmission
n = 18,461

No 30-day readmission
n = 164,471

Died within 30 days
n = 8584

Alive at 30 days postdischarge
n = 155,887

30-day potentially
avoidable
readmission
n = 59,045
Figure 2. Index hospital discharge outcomes and frequencies.
348
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Table 3. Most frequent causes of index hospitalizations resulting in potentially avoidable readmissiona

Index hospitalizations (n)
36,032

Five most frequent
causes of index hospitalization
resulting in a 30-d potentially
avoidable readmissionb

30-d potentially avoidable
readmission rate, n (row %)

Five most frequent causes
for potentially avoidable readmissionb

Complication of device; implant or graft

8264 (22.9)

Complication of device; implant or graft
Septicemia
Hypertension with complications and secondary hypertension
Congestive heart failure; nonhypertensive
Complications of surgical procedures or medical care

19,072

Congestive heart failure; nonhypertensive

5290 (27.7)

Congestive heart failure; nonhypertensive
Hypertension with complications and secondary hypertension
Complication of device; implant or graft
Fluid and electrolyte disorder
Respiratory failure; insufﬁciency; arrest

15,824

Hypertension with complications and secondary hypertension

4018 (25.4)

Hypertension with complications and secondary hypertension
Complication of device; implant or graft
Congestive heart failure; nonhypertensive
Fluid and electrolyte disorder
Diabetes mellitus with complications

12,136

Diabetes mellitus with complications

3395 (28.0)

Diabetes mellitus with complications
Complication of device; implant or graft
Complications of surgical procedures or medical care
Hypertension with complications and secondary hypertension
Septicemia

12,472

Septicemia

3131 (25.1)

Septicemia
Complication of device; implant or graft
Congestive heart failure; nonhypertensive
Hypertension with complications and secondary hypertension
Diabetes mellitus with complications

a

Index hospitalization causes listed are in order of decreasing total number of 30-day potentially avoidable readmission.
As a percentage of index hospitalization, and identified by single-level Clinical Classification Software category as follows: Congestive Heart Failure: 108; Hypertension with Complications: 99; Fluid and Electrolyte Disorders: 55; Respiratory Failure, insufficiency or arrest: 131; Device Complications (Implant or Graft): 237; Septicemia: 2; Diabetes Mellitus with
Complications: 50.
b

in a 30-day PAR, followed by congestive failure, and
hypertension. The index hospital discharge cause
with the highest 30-day PAR rate was diabetes mellitus with complications (28.0%), followed by
congestive heart failure (27.7%). Causes of 30-day
PAR are most commonly the same as reason for
index hospital discharge; the most frequent 30-day
PAR cause was identical to the corresponding index
hospital discharge cause in all of our reported
categories.
The geographic distribution of 30-day PAR varied
by state, with percentages ranging from 12% to 31%,
as a proportion of index hospital discharges
(Figure 3). The highest 30-day PARs were in Nevada
(30.6%), Washington, DC (28.3%), and Maryland
(27.5%).
Multivariable 30-Day Potentially Avoidable
Readmission
All baseline patient demographic characteristics were
examined in unadjusted analysis, and the following
were signiﬁcantly associated with 30-day PAR
(P < 0.05) and were included in the ﬁnal multivariable
model: age, length of stay, number of prior admissions,
Kidney International Reports (2018) 3, 343–355

HD vintage years, gender, race, ethnicity, ESKD primary cause, employment status, type of admission
(surgical, medical with surgery, medical without surgery), dialysis facility, and comorbidity index.
Geographic-level median income and index admission
primary diagnosis were not signiﬁcantly associated
with 30-day PAR and therefore not included in the
ﬁnal multivariable model.
In adjusted analyses that controlled for patient
comorbidities using a validated comorbidity index,34
patient characteristics associated with increased odds
of 30-day PAR included greater number of prior hospitalizations (odds ratio [OR] 1.40; 95% conﬁdence interval [CI] 1.36–1.45 for >3 compared with none), black
race (OR 1.06; 95% CI 1.03–1.08 compared with white
race), unemployed status (OR 1.07; 95% CI 1.01–1.13
compared with employed/student), HD at a for-proﬁt
HD facility (OR 1.05; 95% CI 1.02–1.07 compared
with nonproﬁt facility), and higher comorbidity index
(OR 1.19; 95% CI 1.18–1.19 per 2-unit increase). Older
age (OR 0.93; 95% CI 0.92–0.94 per 10-year age
increase) and longer HD vintage (OR 0.77; 95% CI
0.75–0.80 for >3 years compared with <1 year) was
associated with decreased risk of 30-day PAR (Table 4).
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Figure 3. Geographic variation in 30-day potentially avoidable readmission. *Percentages of 30-day potentially avoidable readmission presented
as proportion of index hospitalization. Reproduced with permission from Jonathan Amalfitano, Strategic Planning, Northwell Health, New Hyde
Park, NY.

Index hospitalization characteristics associated with
higher risk 30-day PAR included longer length of index hospital stay (OR 1.30; 95% CI 1.26–1.34 for >8
days compared with 0–4 days), and index hospitalizations that involved a surgical procedure. Compared
with surgical index hospitalizations, medical index
hospitalizations that did not involve surgery had a
lower risk of 30-day PAR (OR 0.86; 95% CI 0.82–0.90)
(Table 4). Additionally, medical admissions with a
surgical procedure had greater odds of PAR as
compared with medical admissions without a surgical
procedure (OR 1.08, 95% CI 1.03–1.13).
To assess for unique risk factors for PAR, models were
repeated using all readmission, all readmission þ death
and PAR þ death as the main outcomes of interest
(Supplementary Tables S1–S3). When comparing the
original model with the “all readmission” model, ﬁndings
were similar with the addition that geographic-level median income was now signiﬁcant (OR 1.01; 95% CI 1.00–
1.01; P ¼ 0.0110) for every $10,000 increase in income.
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When comparing the original model to “all readmission þ
death,” ﬁndings were similar with the exception that age
was no longer signiﬁcant. When comparing the original
model to PAR þ death, ﬁndings are similar with the
exception of increasing age associated with the increased
risk of the composite outcome of PAR þ death (OR 1.01;
95% CI 1.00–1.02; P ¼ 0.0110). Finally, in our original
analysis, surgical index admissions were associated with
the highest risk of 30-day PAR. However, medical index
admissions have the highest risk when death is included
as a composite outcome with either the “all readmission”
or “PAR” outcome.
Time to Potentially Avoidable Readmission
The cumulative incidence function was estimated with
competing risks data. The 5-, 15-, and 30-day potentially avoidable readmission cumulative incidences
were 6.0%, 15.1%, and 23.8%, respectively. Using
standard survival analysis procedures (Kaplan-Meier
product-limit method) the 5-, 15-, and 30-day failure
Kidney International Reports (2018) 3, 343–355
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Table 4. Multivariable logistic regression model of association of
potentially avoidable readmission association with patient and index
hospitalization characteristics among prevalent patients with ESKD
on hemodialysis in the United States
Characteristic
Age, yr (unit [ 10 yr)

OR (95% CI)
0.93 (0.92–0.94)

P
<0.001

Length of stay of index hospitalization, d
Ref

–

>4–8

1.12 (1.10–1.16)

<0.001

>8

1.30 (1.26 1.34)

<0.001

0–4

Number of prior admissions (12 months prior)
None

Ref

–

1–3

1.03 (1.00–1.06)

0.02

>3

1.40 (1.36–1.45)

<0.001

Dialysis vintage, yr
<1

Ref

–

1–3

0.84 (0.81–0.87)

<0.001

>3

0.77 (0.75–0.80)

<0.001

Gender
Ref

–

1.03 (1.01–1.06)

0.003

Male
Female
Race
White

Ref

–

Black

1.06 (1.03–1.08)

<0.001

Asian

1.07 (0.99–1.14)

0.05

Native American

0.88 (0.81–0.97)

0.01

Other

1.13 (0.98–1.31)

0.09

Unknown

1.12 (0.63–1.98)

0.70

Ethnicity
Ref

–

Hispanic

1.01 (0.97–1.04)

0.75

Unknown

0.84 (0.76–0.94)

0.0014

Non-Hispanic

ESKD primary cause
Ref

–

0.99 (0.95–1.04)

0.81

Glomerulonephritis/cystic kidney
Diabetes
Hypertension

1.05 (1.01–1.10)

0.01

Other

1.12 (1.07–1.18)

<0.001

Employment status
Ref

–

1.02 (0.95–1.10)

0.61

Employed/Student
Homemaker
Retired – Disability/Medical LOA

0.98 (0.94–1.04)

0.67

Retired – Age

1.02 (0.96–1.08)

0.49

Unemployed

1.07 (1.01–1.13)

0.02

Unknown/Other

1.07 (0.98–1.17)

0.15

Type of index admission
Ref

–

Medical without surgery

0.85 (0.81–0.89)

<0.001

Medical with surgery

0.91 (0.89–0.94)

<0.001

Surgical

index hospitalizations. The instantaneous hazard rate
for potentially avoidable readmission varied with
length of time from index hospital discharge. The
estimated hazard rate increased for approximately the
ﬁrst week postdischarge then decreased until day 25
with a subsequent recurrent increase (Figure 4).
DISCUSSION
Using data from a national longitudinal database of US
HD patients, this study explored the frequency, causes,
predictors, and time to potentially avoidable readmission to hospital within 30 days of an index hospital
discharge in patients with ESKD receiving HD treatment. Nearly three-quarters (70.1%) of all 30-day
readmissions may have been potentially avoidable.
Geographic frequency of 30-day PAR varied by state.
The most common medical index hospital discharge
condition that resulted in a 30-day PAR was heart
failure. The most common surgical index hospital
discharge condition that resulted in a 30-day PAR was
a vascular procedure. In adjusted analysis, characteristics associated with higher 30-day PAR included
younger age, shorter HD vintage, greater number of
prior hospitalizations, black race, unemployed status,
HD treatment at a for-proﬁt center, and longer length
of index hospital stay. Increasing age was associated
with PAR þ death, suggesting that older patients are
more likely to die and younger patients are more likely
to be readmitted for PAR. The estimated hazard rate for
potentially avoidable readmission varied from day 0 to
day 30 postdischarge.
Observational studies have described risk factors for
readmission to hospital in patients with ESKD,
including anemia,37,38 low serum albumin,37,39 and
comorbid conditions, such as cerebrovascular accident,
peripheral vascular disease, and depression.40 Given
the observational study designs and variable deﬁnitions of readmission, comparison across studies is
0.012

Nonproﬁt

Ref

–

Proﬁt

1.05 (1.02–1.07)

0.0013

Unknown

0.99 (0.95–1.05)

0.85

1.19 (1.18–1.19)

<0.001

Comorbidity Index (unit [ 2)

CI, conﬁdence interval; ESKD, end-stage kidney disease; LOA, leave of absence; OR,
odds ratio.

estimates of potentially avoidable readmission were
6.1%, 15.9%, and 25.8%, respectively. It is possible
that the different methods yield similar results due to
the relatively small number of deaths (3.5%),
unplanned readmissions (7.5%), and planned readmissions (2.3%), representing only 13.2% of the total
Kidney International Reports (2018) 3, 343–355
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Figure 4. Hazard function for potentially avoidable readmission.
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limited. A recent study by Harel et al.41 using administrative data from Ontario, Canada, reported 17% of
in-center HD patients were readmitted, 27% visited the
emergency department, and 7.5% died with 30 days of
an index hospital discharge. Although this study
extends the understanding of postdischarge resource
utilization and patient outcomes to include emergency
room visits, comparison with the current US in-center
HD population is limited. The proportion of patients
with 30-day readmission is substantially lower than
observed in the United States since the USRDS reports a
35.2% all-cause 30-day readmission risk.5 Harel et al.41
proposed several reasons for this observed difference in
30-day readmission risk between Canada and the
United States, including variations in HD care provision, reimbursement policies, and HD unit location in
hospitals versus free-standing units. Prospective
studies are required to test these hypotheses in
controlled trials. Another recent study by Flythe
et al.42 assessed risk factors for 30-day readmission to
hospital, and excluded scheduled readmissions for
vascular access or other planned procedures (as determined by admission history and physical review).
Unlike our study, Flythe et al.42 did not distinguish
“unplanned but unavoidable” readmissions from
potentially avoidable readmissions. Of 349 included
patients, 32.1% had a 30-day readmission. Similar to
our study, comorbid illness and greater number of
hospitalizations in the prior 12 months were associated
with 30-day readmission. Prescription medication
changes (from higher to lower number at index hospital discharge), and weekend discharge day were
identiﬁed by Flythe et al.42 as associated with 30-day
readmissions, as possibly actionable risk factors for
30-day readmission. Unlike Flythe et al.,42 we identiﬁed several patient-related risk factors, including
younger age, female gender, black race, and shorter
dialysis vintage, which were not identiﬁed by those
authors. These characteristics may be associated with
patients who are particularly ill and/or disadvantaged
and thus prone to potentially avoidable 30-day readmission. Although the computerized algorithm we used
cannot perfectly distinguish avoidable from unavoidable readmissions, we created a cohort enriched with
avoidable readmissions to better identify risk factors
for potentially avoidable readmission in HD patients
than would otherwise be possible. A future full validation study in HD patients should be performed,
given that our results identify a potentially important
performance gap.
Previous studies have described associations between
interventions and lower risk of hospital readmission in
HD patients. Chan et al.24 reported that hemoglobin
monitoring, erythropoietin dose adjustments, and
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vitamin D administration after hospital discharge were
associated with a 15% lower risk of readmission than
others. Erickson et al.25 reported a 3.5% reduction in
the probability of readmission with one additional
nephrologist provider visit in the month following a
hospital discharge. These observational study results
suggest that higher intensity of outpatient care in
the period following a hospital discharge could reduce
the risk of a subsequent readmission. However, the
components of such a targeted intervention require
characterization and study through prospective
controlled trials.
The lack of evidence-based strategies to reduce
readmission risk in HD patients is disquieting, in light
of the Standardized Readmission Ratio component
of the End-Stage Renal Disease Quality Incentive
Program.43 This program is a “pay-for-performance”
program administered by the Centers for Medicare and
Medicaid Services. Beginning in payment year 2017, a
high Standardized Readmission Ratio rate could
contribute to a total performance score that causes
payment reductions to HD facilities. In other high-risk
populations, such as skilled nursing facility residents,
pay-for-performance readmission quality measures
attempt to include only potentially avoidable readmissions16 to reduce the misaligned incentives to defer
hospitalization of a skilled nursing facility resident for
elective or beneﬁcial care.
Our results provide the groundwork for several
avenues of future research aimed at reducing avoidable
readmissions in HD patients. First, we demonstrate a
substantial difference in risk between readmissions
considered potentially avoidable and those that were
unplanned and also unavoidable. We show that the
estimated hazard rate of 30-day PAR varies with a late
rise at 25 days post hospital discharge, suggesting that
the postdischarge 30-day window conventionally used
to identify readmissions may be inappropriately short.
Thus, research is required to develop a standardized
measure of avoidable readmission tailored to HD
patients with the appropriate time span after hospital
discharge. This will facilitate comparison of results
across research studies and provide a meaningful target
for improvement through prospective interventional
studies. Second, our study identiﬁes several factors
associated with increased risk of 30-day PAR in HD
patients that can be used in subsequent patient-level
studies for the derivation and validation of a clinical
prediction model. This would beneﬁt clinicians and
policy makers by focusing intensive postdischarge care
on patients at highest risk of readmission, and facilitate
researchers in enrolling HD patients at highest risk into
clinical trials testing interventions to reduce readmission risk. Third, our reported baseline risk
Kidney International Reports (2018) 3, 343–355
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estimates of potentially avoidable readmission can be
used in sample size calculations for future randomized
controlled trials. Finally, the wide geographic variation
we report across the United States implies that
improvement in potentially avoidable readmission risk
may be possible; however, more detailed study is
required to elucidate the processes and practices which
effectively reduce potentially avoidable readmissions
that are nationally or regionally transferrable.
In this study, the outcome of 30-day PAR was
determined using a computer algorithm for administrative data validated in a general medicine population.
There are several reasons that rationalize the use of this
algorithm in the HD population, including the
following: (i) the proportion of potentially avoidable
readmission we report is similar to studies of other
patient populations. A MedPac report using 3M classiﬁcation software identiﬁed 76% of all 30-day readmissions as potentially preventable from 2005 Medicare
discharge claims data.44 A single-center study of acute
general medical hospitalizations deemed 71% of readmissions potentially avoidable.15 Finally, a recent systematic review of potentially avoidable readmissions
found 8 studies with more than 50% of readmissions
classiﬁed as potentially avoidable.10 (ii) Our analysis
identiﬁes several predictors of potentially avoidable
readmission which are consistent with the algorithm
developed by Halfon et al.,19 including previous hospitalizations, high comorbidity index, and long length
of stay. (iii) Although this algorithm was originally
derived and validated in Switzerland, it has been used
with good to excellent discriminatory power and calibration in US general medical populations,20 and in US
populations with comorbid disease, including cancer45
and chronic kidney disease.46
Our study should be qualiﬁed by several potential
limitations. (i) We underestimated the proportion of
planned 30-day readmissions, as hospital discharges for
rehabilitation, psychiatric reasons, cancer treatments,
and renal transplants were excluded. Our study
observed that 6.8% of all 30-day readmissions were
planned, compared with approximately 10% in the
general medicine population.6 (ii) Exclusion of these
planned hospital stays slightly reduced the number of
denominator index hospital discharges and thus
modestly increased the reported proportion of 30-day
PAR. Exclusion of these hospital discharges was an
intentional component of our study design to limit the
index cohort to acute hospitalizations of patients
who were in a more homogeneous “at-risk” set for
potentially avoidable readmission upon discharge. (iii)
Data from 2008 were used for this analysis, and some
trends in ESKD care may not reﬂect current practice.
However, all-cause 30-day readmission risk has
Kidney International Reports (2018) 3, 343–355

remained relatively ﬁxed since 2008, ranging from
35.2% to 36.3% as indicated in annual USRDS data
reports,5,47,48 lending validity to our results in the
present day. (iv) We are limited by the use of a national
database, where medical evidence forms and claimsbased data may have misclassiﬁed variables for medical conditions and encounters. In particular, the 2728
Medical Evidence report has very good to excellent
speciﬁcity, but comorbid conditions are underreported.49 Given our use of administrative data, we
did not have access to laboratory values and medication
utilization, which would augment the risk predictors
identiﬁed in this study.
ESKD patients on maintenance HD are at high risk
for 30-day readmission, and a large proportion of these
readmissions may have been prevented with optimized
transitional care. The ESKD patient’s requisite
follow-up in the outpatient HD unit provides a unique
opportunity to streamline and facilitate hospital
discharge processes and coordinate outpatient care.
Given the high ﬁnancial costs to health systems and
emotional and societal costs to patients and their
caregivers, future research should focus on developing
and testing cost-effective interventions to reduce
this high risk of readmission and improve patient
outcomes.
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